Second Shot In Clinical Trial Of Novavax COVID Vaccine Comes With A Dose Of Confidence

Data from studies done in the United Kingdom show the COVID-19 vaccine made by Novavax is roughly 90% effective. That’s great news as the Phase 3 clinical trial of that vaccine in the United States is underway.